XML 26 R15.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Intangible Assets | 6 Months Ended
--- | ---
Jun. 30, 2018
Intangible Assets, Net (Excluding Goodwill) [Abstract] |
Intangible Assets | INTANGIBLE ASSETS The following table summarizes the carrying amount of our intangible assets, net (in millions):
|  | June 30, 2018 |  | December 31, 2017
Finite-lived intangible assets |  | $ | 13,746 |  |  | $ | 14,350 |
Indefinite-lived intangible assets |  | 2,750 |  |  | 2,750 |
Total intangible assets |  | $ | 16,496 |  |  | $ | 17,100 |
The following table summarizes our finite-lived intangible assets (in millions):
|  | June 30, 2018 |  | December 31, 2017
|  | Gross Carrying Amount |  | Accumulated Amortization |  | Foreign Currency Translation Adjustment |  | Net Carrying Amount |  | Gross Carrying Amount |  | Accumulated Amortization |  | Net Carrying Amount
Intangible asset - sofosbuvir |  | $ | 10,720 |  |  | $ | (3,205 | ) |  | $ | — |  |  | $ | 7,515 |  |  | $ | 10,720 |  |  | $ | (2,855 | ) |  | $ | 7,865 |
Intangible asset - axicabtagene ciloleucel (DLBCL) |  | 6,200 |  |  | (244 | ) |  | — |  |  | 5,956 |  |  | 6,200 |  |  | (72 | ) |  | 6,128 |
Intangible asset - Ranexa |  | 688 |  |  | (622 | ) |  | — |  |  | 66 |  |  | 688 |  |  | (566 | ) |  | 122 |
Other |  | 546 |  |  | (334 | ) |  | (3 | ) |  | 209 |  |  | 546 |  |  | (311 | ) |  | 235 |
Total |  | $ | 18,154 |  |  | $ | (4,405 | ) |  | $ | (3 | ) |  | $ | 13,746 |  |  | $ | 18,154 |  |  | $ | (3,804 | ) |  | $ | 14,350 |
Amortization expense related to finite-lived intangible assets is included in Cost of goods sold on our Condensed Consolidated Statements of Income and totaled $300 million and $601 million for the three and six months ended June 30, 2018, respectively, and $210 million and $420 million for the three and six months ended June 30, 2017, respectively. As of June 30, 2018, the estimated future amortization expense associated with our finite-lived intangible assets is as follows (in millions):
Fiscal Year |  | Amount
2018 (remaining six months) |  | $ | 602 |
2019 |  | 1,088 |
2020 |  | 1,064 |
2021 |  | 1,063 |
2022 |  | 1,063 |
Thereafter |  | 8,866 |
Total |  | $ | 13,746 |

X
- Definition The entire disclosure for all or part of the information related to intangible assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -URI http://asc.fasb.org/topic&trid=2144416 + Details
Name: | us-gaap_IntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration